BioCentury | Feb 10, 2014
Company News
Eboo Pharmaceuticals, FPRT Bio, MentiNova, Michael J. Fox Foundation For Parkinson's Research neurology news
...The foundation named Eboo, FPRT and MentiNova as the 2H13 participants in The Michael J. Fox...
...close in May. FPRT has rights to the product from Xencor Inc. (NASDAQ:XNCR, Monrovia, Calif.). MentiNova...
...disorders. The injectable compound, which is co-administered with levodopa, was originally developed to manage pain. MentiNova...
...close in May. FPRT has rights to the product from Xencor Inc. (NASDAQ:XNCR, Monrovia, Calif.). MentiNova...
...disorders. The injectable compound, which is co-administered with levodopa, was originally developed to manage pain. MentiNova...